Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-19
2011-07-19
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S387100, C530S387300, C530S388150, C530S388200, C536S023500, C435S069100, C435S320100, C435S325000, C435S326000, C435S331000
Reexamination Certificate
active
07982016
ABSTRACT:
The present disclosure provides compositions and methods relating to antigen binding proteins which bind to human thymic stromal lymphopoietin (TSLP), including antibodies. In particular embodiments, the disclosure provides fully human, humanized and chimeric anti-TSLP antibodies and derivatives of such antibodies. The disclosure further provides nucleic acids encoding such antibodies and antibody fragments and derivatives, and methods of making and using such antibodies including methods of treating and preventing TSLP-related inflammatory and fibrotic disorders.
REFERENCES:
patent: 5011912 (1991-04-01), Hopp et al.
patent: 6555520 (2003-04-01), Sims et al.
patent: 6844170 (2005-01-01), Moore et al.
patent: 2002/0146819 (2002-10-01), Sims et al.
patent: 2003/0099947 (2003-05-01), Bazan et al.
patent: 2003/0186875 (2003-10-01), De Waal Malefyt et al.
patent: 2005/0249712 (2005-11-01), Leonard et al.
patent: 2009/0186022 (2009-07-01), Bardroff et al.
patent: 93/21946 (1993-11-01), None
patent: 95/00103 (1995-01-01), None
patent: 98/36061 (1998-08-01), None
patent: 99/47538 (1999-09-01), None
patent: 00/17362 (2000-03-01), None
patent: 00/29581 (2000-05-01), None
patent: 00/39149 (2000-07-01), None
patent: 01/12672 (2001-02-01), None
patent: 01/62272 (2001-08-01), None
patent: 01/87328 (2001-11-01), None
patent: 02/00723 (2002-01-01), None
patent: 02/00724 (2002-01-01), None
patent: 03/065985 (2003-08-01), None
patent: 03/099823 (2003-12-01), None
patent: 2004/022718 (2004-03-01), None
patent: 2005/007186 (2005-01-01), None
patent: 2006/023791 (2006-03-01), None
patent: 2007/112146 (2007-10-01), None
patent: 2008/076321 (2008-06-01), None
patent: 2008/155365 (2008-12-01), None
Mariuzza et al. (Annu. Rev. Biophys. Biophys. Chem. 1987; 16: 139-159).
Gussow et al. (Methods in Enzymology. 1991; 203: 99-121).
Giusti et al. (Proc. Natl. Acad. Sci. USA. May 1987; 84 (9): 2926-2930).
Chien et al. (Proc. Natl. Acad. Sci. USA. Jul. 1989; 86 (14): 5532-5536).
Caldas et al. (Mol. Immunol. May 2003; 39 (15): 941-952).
De Pascalis et al. (J. Immunol. 2002; 169 (6): 3076-3084).
Wu et al. (J. Mol. Biol. Nov. 19, 1999; 294 (1): 151-162).
Casset et al. (Biochem. Biophys. Res. Commun. Jul. 18, 2003; 307 (1): 198-205).
MacCallum et al. (J. Mol. Biol. Oct. 11, 1996; 262 (5): 732-745).
Holm et al. (Mol. Immunol. Feb. 2007; 44 (6): 1075-1084).
Rudikoff et al. (Proc. Natl. Acad. Sci. USA. 1982; 79 (6): 1979-1983).
Gao et al., “Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis,” Biol Pharm Bull 27(9):1376-1381, 2004.
Shimizu et al., “The appearance of S-100 protein-positive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia,” Respir Med 96:770-776, 2002.
Williams et al., “Identification of spontaneous feline idiopathic pulmonary fibrosis,” Chest 125:2278-2288, 2004.
Ramalingam et al., Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin, J Immunol 182:6452-6459, 2009.
Marchal-Sommé et al., “Dendritic cells accumulate in human fibrotic interstitial lung disease,” Am J Respir Crit Care Med 176:1007-1014, 2007.
Semlali et al., “Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway,” J Allergy Clin Immunol 125:844-850, 2010.
Wilson and Wynn, “Pulmonary fibrosis: pathogenesis, etiology and regulation,” Mucosal Immunol 2(2):103-121, 2009.
Davies, “The role of the epithelium in airway remodeling in asthma,” Proc Am Thorac Soc 6:678-682, 2009.
Allakhverdi et al., “Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells,” J Exp Med, 204(2):253-258, 2007.
Barnes et al., “New therapeutic approaches,” Br Med Bull 48(1):231-247, 1992.
Barnes, “Cytokine-directed therapies for asthma,” J Allergy Clin Immunol 108(Suppl.2):S72-S76, 2001.
Barnes, “Corticosteroid effects on cell signalling,” Eur Respir J 27(2):413-426, 2006.
Bazan, “Haemopoietic receptors and helical cytokines,” Immunol Today 11:350-354, 1990.
Blyth et al., “Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody,” Am J Respir Cell Mol Biol 23(2)241-246, 2000.
Borish et al., “Efficacy of soluble IL-4 receptor for the treatment of adults with asthma,” J Allergy Clin Immunol 107 (6):963-970, 2001.
Bork et al., “Go hunting in sequence databases but watch out for the traps,” Trends Genet 12:425-427, 1996.
Bork, “Powers and pitfalls in sequence analysis: the 70% hurdle,” Genome Res 10:398-400, 2000.
Brenner, “Errors in genome annotation,” Trends Genet 15:132-133, 1999.
Burdach et al., “The physiologic role of interleukin-3, interleukin-5, granulocyte-macrophage colony-stimulating factor, and the βc receptor system,” Curr Opin Hematol 5:177-180, 1998.
Candéias et al., “IL-7 receptor and VDJ recombination: trophic versus mechanistic actions,” Immunity 6:501-508, 1997.
Cao et al., “Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) γ chain: chromosomal mapping and tissue specificity of IL-2R γ chain expression,” Proc Natl Acad Sci USA 90:8464-8468, 1993.
Cohn et al., “T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production,” J Exp Med 190(9):1309-1317, 1999.
Cunningham and Wells, “High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis,” Science 244:1081-1085, 1989.
Database EMBL Online Accession No. AB031333, Kitamura and Fujio,Mus musculusmRNA for cytokine receptor deltal, complete cds, Feb. 24, 2000.
Database EMBL Online Accession No. AB039945, Hiroyama et al.,Mus musculusCRLM2 mRNA for cytokine receptor like molecule 2, complete cds, Mar. 14, 2000.
Database EST, Accession No. AA021949, Marra et al., Marra M/Mouse EST Project, Jan. 21, 1997.
Doerks et al., “Protein annotation: detective work for function prediction,” Trends Genet 14:248-250, 1998.
DosReis et al., “The central role of Fas-ligand cell signaling in inflammatory lung diseases,” J Cell Mol Med 8 (3):285-293, 2004.
Fujio et al., “Molecular cloning of a novel type I cytokine receptor similar to the common gamma chain,” Blood 95 (7):2204-2211, 2000.
Garcia et al., “Evaluation of inflammatory cytokine secretion by human alveolar macrophages,” Mediators Inflamm 8 (1):43-51, 1999.
Giri et al., “Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15,” EMBO J 13:2822-2830, 1994.
Grunewald et al., “An antagonistic IL-4 mutant prevents Type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo,” J Immunol 160(8):4004-4009, 1998.
Guthridge et al., “Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors,” Stem Cells 16:301-313, 1998.
He et al., “The common γ-chain of cytokine receptors regulates intrathymic T cell development at multiple states,” J Immunol 158:2592-2599, 1997.
He et al., “Small-molecule inhibition of TNF-α,” Science 310(5750):1022-1025, 2005.
Hirano et al., “Signaling mechanisms through gp130: a model of the cytokine system,”Cytokine Growth Factor Rev 8:241-252, 1997.
Hiroyama et al., “Molecular cloning and characterization of CRLM-2, a novel type I cytokine receptor preferentially expressed in hematopoietic cells,” Biochem Biophys Res Commun 272(1):224-229, 2000.
Hosaka, et al., “Arg-X-Lys/Arg-Arg Motif as a signal for precursor cleavage catalyzed by furin within the
Comeau Michael R.
Mehlin Christopher
Smothers James F.
Yoon Bo-Rin P.
Amgen Inc.
Rawlings Stephen L
Wrona Thomas J.
LandOfFree
Antigen binding proteins capable of binding thymic stromal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen binding proteins capable of binding thymic stromal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen binding proteins capable of binding thymic stromal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739794